Liquidia (LQDA) EBIT Margin (2020 - 2026)
Liquidia (LQDA) recorded quarterly EBIT Margin of 46.29% in Q1 2026, up 115.28% quarter-over-quarter from 21.5% in Q4 2025, and up 118171.0% on a YoY basis from N/an in Q1 2025.
Liquidia (LQDA) EBIT Margin (2020 - 2026) Analysis & Trends
Liquidia's EBIT Margin history runs 7 years deep, the most recent figure standing at 46.29% for Q1 2026.
- In Q1 2026, EBIT Margin rose 118171.0% year-over-year to 46.29%; the TTM figure through Mar 2026 stood at 15.81% (up 92021.0% YoY), while the FY2025 annual figure was 32.45%, up 83418.0% from the prior year.
- EBIT Margin was 46.29% for Q1 2026 at Liquidia, up from 21.5% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 46.29% in Q1 2026 to a low of 1237.81% in Q4 2024.
- Historically, EBIT Margin has averaged 459.38% across 5 years, with a median of 414.43% in 2022.
- The sharpest annual moves came in 2024 and 2025: EBIT Margin slumped 76360 bps in 2024, then surged 125932 bps in 2025.
- A 5-year view of EBIT Margin shows it stood at 121.21% in 2022, then sank by 381 bps to 583.45% in 2023, then tumbled by 112 bps to 1237.81% in 2024, then soared by 102 bps to 21.5% in 2025, then soared by 115 bps to 46.29% in 2026.
- The last three EBIT Margin figures came in at 46.29% (Q1 2026), 21.5% (Q4 2025), and 3.25% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -122.23% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -12.88% |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 46.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.29% |
| Dec 31, 2025 | 21.50% |
| Sep 30, 2025 | 3.25% |
| Jun 30, 2025 | -424.41% |
| Mar 31, 2025 | -1,135.42% |
| Dec 31, 2024 | -1,237.81% |
| Sep 30, 2024 | -656.23% |
| Jun 30, 2024 | -743.29% |
| Mar 31, 2024 | -969.08% |
| Dec 31, 2023 | -583.45% |
| Sep 30, 2023 | -404.87% |
| Jun 30, 2023 | -476.91% |
| Mar 31, 2023 | -205.48% |
| Dec 31, 2022 | -121.21% |
| Sep 30, 2022 | -279.02% |
| Jun 30, 2022 | -228.94% |
| Mar 31, 2022 | -414.43% |
| Dec 31, 2021 | -353.41% |
| Sep 30, 2021 | -222.71% |
| Jun 30, 2021 | -188.21% |